Technology
Health
Biotechnology
Leap Therapeutics
$2.039876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$2.03
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.04 (2.01%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell LPTX and other stocks, options, ETFs, and crypto commission-free!
About LPTX
Leap Therapeutics, Inc. Common Stock, also called Leap Therapeutics, is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. Read More Its clinical stage programs are DKN-01 and TRX518. The company was founded on January 3, 2011 and is headquartered in Cambridge, MA.
Employees
25
Headquarters
Cambridge, Massachusetts
Founded
2011
Market Cap
44.30M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
487.23K
High Today
$2.08
Low Today
$2.01
Open Price
$2.03
Volume
285.85K
52 Week High
$8.75
52 Week Low
$1.35
Collections
Technology
Health
Biotechnology
Medical
Therapy
Biopharmaceutical
Cancer Prevention
Pharmaceutical
Price Paid on Robinhood
13% Lower
Right Now
52 Week Low
$1.35
Average Price Paid
$2.32
52 Week High
$9.45
LPTX Earnings
-$0.85
-$0.70
-$0.56
-$0.41
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 8, Pre-Market